eLaws | eCases | United States Code | Federal Courts |
Home » 2012 Issues » 77 FR (12/19/2012) » 2012-30665. Spencer Pharmaceutical Inc.; Order of Suspension of Trading

  2012-30665. Spencer Pharmaceutical Inc.; Order of Suspension of Trading  

  • Start Preamble December 17, 2012.

    It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Spencer Pharmaceutical Inc. (“Spencer”) because of questions regarding the accuracy of publicly disseminated information, concerning, among other things: (1) The company's current financial condition; and (2) statements made by Spencer in press releases concerning, among other things, an unsolicited buyout offer of Spencer by a foreign company.

    The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company.

    Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company, and any equity securities of any entity purporting to succeed to this issuer, is suspended for the period from 9:30 a.m. EST on Monday, December 17, 2012, through 11:59 p.m. EST on Monday, December 31, 2012.

    Start Signature

    By the Commission.

    Elizabeth M. Murphy,

    Secretary.

    End Signature End Preamble

    [FR Doc. 2012-30665 Filed 12-17-12; 11:15 am]

    BILLING CODE 8011-01-P

Visit the Official Version
Leave a Comment

Document Information

Comments Received:
0 Comments
Published:
12/19/2012
Department:
Securities and Exchange Commission
Entry Type:
Notice
Document Number:
2012-30665
Pages:
75223-75223 (1 pages)
Docket Numbers:
File No. 500-1
EOCitation:
of 2012-12-17
PDF File:
2012-30665.pdf